FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle

Xu Feng Qi, Zhuo Ying Chen, Jing Bo Xia, Li Zheng, Hui Zhao, Long Quan Pi, Kyu Sang Park, Soo Ki Kim, Kyu Jae Lee, Dong Qing Cai

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

FoxO3a plays an important role in the aging process and decreases with age. However, the potential regulatory roles of FoxO3a in processes involved in cardiac microvascular endothelial cell (CMEC) senescence, and its underlying molecular mechanisms have not been elucidated. This study demonstrates that FoxO3a is deactivated in senescent CMECs together with the inhibition of proliferation and tube formation. Furthermore, the activation of the antioxidant enzymes catalase and SOD, downstream FoxO3a targets, was significantly decreased, thereby leading to cell cycle arrest in G1-phase by increased ROS generation and subsequently the activation of the p27Kip1 pathway. However, FoxO3a overexpression in primary low-passage CMECs not only significantly suppressed the senescence process by increasing the activation of catalase and SOD but also markedly inhibited ROS generation and p27Kip1 activation, although it failed to reverse cellular senescence. Moreover, both cell viability and tube formation were greatly increased by FoxO3a overexpression in primary CMECs during continuous passage. In addition, FoxO3a, deficiency in low-passage CMECs, accelerated the senescence process. Collectively, our data suggest that FoxO3a suppresses the senescence process in CMECs by regulating the antioxidant/ROS/p27Kip1 pathways, although it fails to reverse the cellular senescent phenotype.

Original languageEnglish
Pages (from-to)114-126
Number of pages13
JournalJournal of Molecular and Cellular Cardiology
Volume81
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

CME-Carbodiimide
Cell Cycle
Endothelial Cells
Cell Aging
Catalase
Antioxidants
Enzyme Activation
G1 Phase
Cell Cycle Checkpoints
Cell Survival
Phenotype

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Qi, Xu Feng ; Chen, Zhuo Ying ; Xia, Jing Bo ; Zheng, Li ; Zhao, Hui ; Pi, Long Quan ; Park, Kyu Sang ; Kim, Soo Ki ; Lee, Kyu Jae ; Cai, Dong Qing. / FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle. In: Journal of Molecular and Cellular Cardiology. 2015 ; Vol. 81. pp. 114-126.
@article{c95b871081844b4aa2a06ff6a390c9f1,
title = "FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle",
abstract = "FoxO3a plays an important role in the aging process and decreases with age. However, the potential regulatory roles of FoxO3a in processes involved in cardiac microvascular endothelial cell (CMEC) senescence, and its underlying molecular mechanisms have not been elucidated. This study demonstrates that FoxO3a is deactivated in senescent CMECs together with the inhibition of proliferation and tube formation. Furthermore, the activation of the antioxidant enzymes catalase and SOD, downstream FoxO3a targets, was significantly decreased, thereby leading to cell cycle arrest in G1-phase by increased ROS generation and subsequently the activation of the p27Kip1 pathway. However, FoxO3a overexpression in primary low-passage CMECs not only significantly suppressed the senescence process by increasing the activation of catalase and SOD but also markedly inhibited ROS generation and p27Kip1 activation, although it failed to reverse cellular senescence. Moreover, both cell viability and tube formation were greatly increased by FoxO3a overexpression in primary CMECs during continuous passage. In addition, FoxO3a, deficiency in low-passage CMECs, accelerated the senescence process. Collectively, our data suggest that FoxO3a suppresses the senescence process in CMECs by regulating the antioxidant/ROS/p27Kip1 pathways, although it fails to reverse the cellular senescent phenotype.",
author = "Qi, {Xu Feng} and Chen, {Zhuo Ying} and Xia, {Jing Bo} and Li Zheng and Hui Zhao and Pi, {Long Quan} and Park, {Kyu Sang} and Kim, {Soo Ki} and Lee, {Kyu Jae} and Cai, {Dong Qing}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.yjmcc.2015.01.022",
language = "English",
volume = "81",
pages = "114--126",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle. / Qi, Xu Feng; Chen, Zhuo Ying; Xia, Jing Bo; Zheng, Li; Zhao, Hui; Pi, Long Quan; Park, Kyu Sang; Kim, Soo Ki; Lee, Kyu Jae; Cai, Dong Qing.

In: Journal of Molecular and Cellular Cardiology, Vol. 81, 01.04.2015, p. 114-126.

Research output: Contribution to journalArticle

TY - JOUR

T1 - FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle

AU - Qi, Xu Feng

AU - Chen, Zhuo Ying

AU - Xia, Jing Bo

AU - Zheng, Li

AU - Zhao, Hui

AU - Pi, Long Quan

AU - Park, Kyu Sang

AU - Kim, Soo Ki

AU - Lee, Kyu Jae

AU - Cai, Dong Qing

PY - 2015/4/1

Y1 - 2015/4/1

N2 - FoxO3a plays an important role in the aging process and decreases with age. However, the potential regulatory roles of FoxO3a in processes involved in cardiac microvascular endothelial cell (CMEC) senescence, and its underlying molecular mechanisms have not been elucidated. This study demonstrates that FoxO3a is deactivated in senescent CMECs together with the inhibition of proliferation and tube formation. Furthermore, the activation of the antioxidant enzymes catalase and SOD, downstream FoxO3a targets, was significantly decreased, thereby leading to cell cycle arrest in G1-phase by increased ROS generation and subsequently the activation of the p27Kip1 pathway. However, FoxO3a overexpression in primary low-passage CMECs not only significantly suppressed the senescence process by increasing the activation of catalase and SOD but also markedly inhibited ROS generation and p27Kip1 activation, although it failed to reverse cellular senescence. Moreover, both cell viability and tube formation were greatly increased by FoxO3a overexpression in primary CMECs during continuous passage. In addition, FoxO3a, deficiency in low-passage CMECs, accelerated the senescence process. Collectively, our data suggest that FoxO3a suppresses the senescence process in CMECs by regulating the antioxidant/ROS/p27Kip1 pathways, although it fails to reverse the cellular senescent phenotype.

AB - FoxO3a plays an important role in the aging process and decreases with age. However, the potential regulatory roles of FoxO3a in processes involved in cardiac microvascular endothelial cell (CMEC) senescence, and its underlying molecular mechanisms have not been elucidated. This study demonstrates that FoxO3a is deactivated in senescent CMECs together with the inhibition of proliferation and tube formation. Furthermore, the activation of the antioxidant enzymes catalase and SOD, downstream FoxO3a targets, was significantly decreased, thereby leading to cell cycle arrest in G1-phase by increased ROS generation and subsequently the activation of the p27Kip1 pathway. However, FoxO3a overexpression in primary low-passage CMECs not only significantly suppressed the senescence process by increasing the activation of catalase and SOD but also markedly inhibited ROS generation and p27Kip1 activation, although it failed to reverse cellular senescence. Moreover, both cell viability and tube formation were greatly increased by FoxO3a overexpression in primary CMECs during continuous passage. In addition, FoxO3a, deficiency in low-passage CMECs, accelerated the senescence process. Collectively, our data suggest that FoxO3a suppresses the senescence process in CMECs by regulating the antioxidant/ROS/p27Kip1 pathways, although it fails to reverse the cellular senescent phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84923066166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923066166&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.01.022

DO - 10.1016/j.yjmcc.2015.01.022

M3 - Article

C2 - 25655933

AN - SCOPUS:84923066166

VL - 81

SP - 114

EP - 126

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -